Question to the Department for Science, Innovation & Technology:

To ask His Majesty's Government what evidence they have received about the impact of the loss of the Vaccines Manufacturing and Innovation Centre following its sale.

The decision to sell the Vaccine Manufacturing and Innovation Centre was made by VMIC UK Ltd's Board of Directors. The facility was subsequently sold to Catalent. Once completed, it is intended that the facility will be capable of producing a range of therapeutics and vaccines.

Officials regularly engage with industry stakeholders to understand the wider landscape and implications for vaccine development and manufacturing in the UK and will continue to do so.